114 related articles for article (PubMed ID: 15352251)
1. Proteomic signature of human cancer cells.
Seike M; Kondo T; Fujii K; Yamada T; Gemma A; Kudoh S; Hirohashi S
Proteomics; 2004 Sep; 4(9):2776-88. PubMed ID: 15352251
[TBL] [Abstract][Full Text] [Related]
2. Proteomic signatures for histological types of lung cancer.
Seike M; Kondo T; Fujii K; Okano T; Yamada T; Matsuno Y; Gemma A; Kudoh S; Hirohashi S
Proteomics; 2005 Jul; 5(11):2939-48. PubMed ID: 15996008
[TBL] [Abstract][Full Text] [Related]
3. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteome analysis of three mouse lung adenocarcinoma CMT cell lines with different metastatic potential by two-dimensional gel electrophoresis and mass spectrometry.
Zhang K; Wrzesinski K; Stephen JF; Larsen PM; Zhang X; Roepstorff P
Proteomics; 2008 Dec; 8(23-24):4932-45. PubMed ID: 19003861
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling.
Alfonso P; Cañamero M; Fernández-Carbonié F; Núñez A; Casal JI
J Proteome Res; 2008 Oct; 7(10):4247-55. PubMed ID: 18707159
[TBL] [Abstract][Full Text] [Related]
6. Toward a comprehensive quantitative proteome database: protein expression map of lymphoid neoplasms by 2-D DIGE and MS.
Fujii K; Kondo T; Yamada M; Iwatsuki K; Hirohashi S
Proteomics; 2006 Sep; 6(17):4856-76. PubMed ID: 16888764
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
Zhang H; Wang Y; Chen Y; Sun S; Li N; Lv D; Liu C; Huang L; He D; Xiao X
Lung Cancer; 2007 Jul; 57(1):37-45. PubMed ID: 17418446
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of protein profile of human small cell lung cancer cell line NCI-H446].
Li MY; Xiao ZQ; Li C; Wu XY; Feng XP; Yi H; Li JL; Chen ZC; Chen P; Liang SP
Ai Zheng; 2004 Oct; 23(10):1116-21. PubMed ID: 15473919
[TBL] [Abstract][Full Text] [Related]
10. Protein expression pattern distinguishes different lymphoid neoplasms.
Fujii K; Kondo T; Yokoo H; Yamada T; Matsuno Y; Iwatsuki K; Hirohashi S
Proteomics; 2005 Nov; 5(16):4274-86. PubMed ID: 16206328
[TBL] [Abstract][Full Text] [Related]
11. Clinical cancer proteomics: promises and pitfalls.
Alaiya A; Al-Mohanna M; Linder S
J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
[TBL] [Abstract][Full Text] [Related]
12. [Differential proteomic analysis of drug resistant A549/DDP cell lines in human lung adenocarcinoma].
Wei R; Xie Y; Yang D; He L; Peng F; Sheng L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):854-60. PubMed ID: 20818079
[TBL] [Abstract][Full Text] [Related]
13. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
15. [Comparative proteomic analysis of human large cell lung cancer cell line with high and low metastasis potentials].
Gao LW; Zhu W; Feng ZH; An N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):706-10. PubMed ID: 19024295
[TBL] [Abstract][Full Text] [Related]
16. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
17. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection.
Yao H; Zhang Z; Xiao Z; Chen Y; Li C; Zhang P; Li M; Liu Y; Guan Y; Yu Y; Chen Z
Lung Cancer; 2009 Jul; 65(1):41-8. PubMed ID: 19058872
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin.
Nishimori T; Tomonaga T; Matsushita K; Oh-Ishi M; Kodera Y; Maeda T; Nomura F; Matsubara H; Shimada H; Ochiai T
Proteomics; 2006 Feb; 6(3):1011-8. PubMed ID: 16400690
[TBL] [Abstract][Full Text] [Related]
19. Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments.
Martín B; Sanz R; Aragüés R; Oliva B; Sierra A
J Proteome Res; 2008 Aug; 7(8):3242-53. PubMed ID: 18582095
[TBL] [Abstract][Full Text] [Related]
20. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
